The LSX World Congress is Europe’s leading event for partnering, strategy, and investment in life sciences, bringing together senior decision-makers from innovative biopharma, medtech, and healthtech companies. With qualified 1:1 partnering at its core, it’s the place to forge meaningful connections, share best practices, and drive transformative innovation in healthcare.

The Novel Conjugates Summit is dedicated to advancing next-generation conjugate therapeutics, including ADCs, by focusing on innovative drug delivery, linker technology, and optimized therapeutic targeting. It brings together experts from biopharma, biotech, and academia to share insights and foster collaboration.